Homograft Versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis
- PMID: 29912740
- DOI: 10.1097/IMI.0000000000000510
Homograft Versus Conventional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis
Abstract
Objective: Surgical management of aortic valve infective endocarditis (IE) with cryopreserved homograft has been associated with lower risk of recurrent IE, but there is equipoise with regard to the optimal prosthesis. This systematic review and meta-analysis were performed to compare outcomes between homograft and conventional prosthesis for aortic valve IE.
Methods: We searched MEDLINE database to September 2017 for studies comparing homograft versus conventional prosthesis. The main outcomes were all-cause mortality, recurrent IE, and reoperation.
Results: There were 18 included comparative observational studies with 2232 patients (median follow up = 5 [interquartile range: 2-7] years, 30% prosthetic valve endocarditis); four studies were adjusted for baseline differences. There were no differences in perioperative mortality or stroke despite a greater proportion of staphylococcal endocarditis, abscess, and root replacements but less multivalve involvement in the homograft group. Long-term outcomes of all-cause mortality [incidence rate ratio (IRR) = 1.03, 95% confidence interval (CI) = 0.81-1.31, P = 0 .83, for unmatched, and IRR = 0.82, 95% CI = 0.36-1.84, P = 0.63, for matched studies], recurrent endocarditis (IRR = 1.01, 95% CI = 0.53-1.93, P = 0.96, for unmatched, and IRR = 1.04, 95% CI = 0.49-2.19, P = 0.92, for matched studies), and reoperation (IRR = 1.60, 95% CI = 0.80-3.21, P = 0.18, for unmatched, and IRR = 3.17, 95% CI = 0.52-19.44, P = 0.21, for matched studies) were not different comparing homograft versus conventional prosthesis. There was a significantly increased need for reoperation with homograft versus mechanical prosthetic valves, but this comparison was based on limited data.
Conclusions: Homografts and conventional prostheses offer similar survival and freedom from recurrent endocarditis and reoperation for aortic valve IE. Homografts may be associated with greater risk of reoperation compared with mechanical valves.
Similar articles
-
Mechanical versus biological valve prosthesis for surgical aortic valve replacement in patients with infective endocarditis.Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):386-392. doi: 10.1093/icvts/ivz122. Interact Cardiovasc Thorac Surg. 2019. PMID: 31121026
-
Are homografts superior to conventional prosthetic valves in the setting of infective endocarditis involving the aortic valve?J Thorac Cardiovasc Surg. 2016 May;151(5):1239-46, 1248.e1-2. doi: 10.1016/j.jtcvs.2015.12.061. Epub 2016 Jan 23. J Thorac Cardiovasc Surg. 2016. PMID: 26936004
-
Emergency surgery for acute infective aortic valve endocarditis: performance of cryopreserved homografts and mode of failure.Eur J Cardiothorac Surg. 1997 Jan;11(1):53-61. doi: 10.1016/s1010-7940(96)01063-9. Eur J Cardiothorac Surg. 1997. PMID: 9030790
-
[Medium-term results of aortic valve replacement with cryopreserved homograft valves: importance of a domestic homograft valve bank].Nihon Geka Gakkai Zasshi. 2007 Mar;108(2):85-8. Nihon Geka Gakkai Zasshi. 2007. PMID: 17405543 Review. Japanese.
-
In patients with severe active aortic valve endocarditis, is a stentless valve as good as the homograft?Interact Cardiovasc Thorac Surg. 2010 Sep;11(3):309-13. doi: 10.1510/icvts.2010.234831. Epub 2010 Jun 4. Interact Cardiovasc Thorac Surg. 2010. PMID: 20525759 Review.
Cited by
-
Homograft Versus Valves and Valved Conduits for Extensive Aortic Valve Endocarditis with Aortic Root Involvement/Destruction: A Systematic Review and Meta-Analysis.Aorta (Stamford). 2022 Apr;10(2):43-51. doi: 10.1055/s-0042-1743110. Epub 2022 Aug 7. Aorta (Stamford). 2022. PMID: 35933984 Free PMC article.
-
Pathology of the Aorta and Aorta as Homograft.J Cardiovasc Dev Dis. 2021 Jun 29;8(7):76. doi: 10.3390/jcdd8070076. J Cardiovasc Dev Dis. 2021. PMID: 34209632 Free PMC article. Review.
-
Hemi-Commando with aortic homograft and atrioventricular septal defect repair for recurrent triple valve endocarditis.JTCVS Tech. 2024 Aug 8;27:76-78. doi: 10.1016/j.xjtc.2024.07.021. eCollection 2024 Oct. JTCVS Tech. 2024. PMID: 39478896 Free PMC article. No abstract available.
-
Ross Procedure Versus Mechanical Versus Bioprosthetic Aortic Valve Replacement: A Network Meta-Analysis.J Am Heart Assoc. 2023 Jan 3;12(1):e8066. doi: 10.1161/JAHA.122.027715. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565200 Free PMC article.
-
A 20-year experience with cryopreserved allografts as the valve replacement of choice in aortic root reconstruction for destructive endocarditis with abscess formation.Interact Cardiovasc Thorac Surg. 2022 Jul 9;35(2):ivac188. doi: 10.1093/icvts/ivac188. Interact Cardiovasc Thorac Surg. 2022. PMID: 35786719 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources